New 52 Week Low Today

Palatin Technologies Inc PTN:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EST
3.85UNCH (UNCH)
Volume
34,343
52 week range
3.78 - 24.00
Loading...
  • Open3.78
  • Day High4.03
  • Day Low3.78
  • Prev Close3.85
  • 52 Week High24.00
  • 52 Week High Date11/29/21
  • 52 Week Low3.78
  • 52 Week Low Date11/29/22

Key Stats

  • Market Cap39.863M
  • Shares Out10.35M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change-69.9

KEY STATS

  • Open3.78
  • Day High4.03
  • Day Low3.78
  • Prev Close3.85
  • 52 Week High24.00
  • 52 Week High Date11/29/21
  • 52 Week Low3.78
  • 52 Week Low Date11/29/22
  • Market Cap39.863M
  • Shares Out10.35M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change-69.9

RATIOS/PROFITABILITY

  • EPS (TTM)-3.91
  • P/E (TTM)-0.99
  • Fwd P/E (NTM)-1.31
  • EBITDA (TTM)-37.952M
  • ROE (TTM)-205.07%
  • Revenue (TTM)2.179M
  • Gross Margin (TTM)88.52%
  • Net Margin (TTM)-1,713.97%
  • Debt To Equity (MRQ)2.71%

EVENTS

  • Earnings Date02/13/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Palatin Technologies Inc

 

Profile

MORE
Palatin Technologies, Inc. is a biopharmaceutical company developing medicines based on molecules that modulate the activity of the melanocortin receptor (MCr) system. The Company’s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need. Its MCr system has effects on inflammation and immune system response, food intake, metabolism, and sexual function. The Company’s commercial product Vyleesi (bremelanotide...
John Prendergast Ph.D.
Independent Chairman of the Board
Carl Spana Ph.D.
President, Chief Executive Officer, Director
Stephen Wills CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
Address
4B Cedar Brook Drive
Cranbury, NJ
08512
United States

Top Peers

SYMBOLLASTCHG%CHG
NTRB
Nutriband Inc
3.98+0.01+0.25%
SYBX
Synlogic Inc
0.595UNCHUNCH
FNCH
Finch Therapeutics Group Inc
0.8737+0.0137+1.593%
CYCN
Cyclerion Therapeutics Inc
0.83UNCHUNCH
ASLN
Aslan Pharmaceuticals Ltd
0.55UNCHUNCH